Application of Human Stem Cells to Model Genetic Sensorineural Hearing Loss and Meniere Disease

Genetic sensorineural hearing loss and Meniere disease have been associated with rare variations in the coding and non-coding region of the human genome. Most of these variants were classified as likely pathogenic or variants of unknown significance and require functional validation in cellular or animal models. Given the difficulties to obtain human samples and the raising concerns about animal experimentation, human-induced pluripotent stem cells emerged as cellular models to investigate the interaction of genetic and environmental factors in the pathogenesis of inner ear disorders. The generation of human sensory epithelia and neuron-like cells carrying the variants of interest may facilitate a better understanding of their role during differentiation. These cellular models will allow us to explore new strategies for restoring hearing and vestibular sensory epithelia as well as neurons. This review summarized the use of human-induced pluripotent stem cells in sensorineural hearing loss and Meniere disease and proposed some strategies for its application in clinical practice.

[1]  A. Gallego-Martinez,et al.  Defective α‐tectorin may involve tectorial membrane in familial Meniere disease , 2022, Clinical and translational medicine.

[2]  H. Okano,et al.  Otic Organoids Containing Spiral Ganglion Neuron-like Cells Derived from Human-induced Pluripotent Stem Cells as a Model of Drug-induced Neuropathy , 2022, Stem cells translational medicine.

[3]  Bernd Fritzsch,et al.  Early Deletion of Neurod1 Alters Neuronal Lineage Potential and Diminishes Neurogenesis in the Inner Ear , 2022, Frontiers in Cell and Developmental Biology.

[4]  G. Zheng,et al.  A Comparison of Local Endolymphatic Sac Decompression, Endolymphatic Mastoid Shunt, and Wide Endolymphatic Sac Decompression in the Treatment of Intractable Meniere's Disease: A Short-Term Follow-Up Investigation , 2022, Frontiers in Neurology.

[5]  E. Erdal,et al.  Transcriptome Dynamics of Human Neuronal Differentiation From iPSC , 2021, Frontiers in Cell and Developmental Biology.

[6]  R. Chai,et al.  Stem Cell-Based Therapies in Hearing Loss , 2021, Frontiers in Cell and Developmental Biology.

[7]  D. Grayden,et al.  Unifying information theory and machine learning in a model of electrode discrimination in cochlear implants , 2021, PloS one.

[8]  J. Lopez-Escamez,et al.  Rare coding variants involving MYO7A and other genes encoding stereocilia link proteins in familial meniere disease , 2021, Hearing Research.

[9]  Aline Yen Ling Wang,et al.  Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate , 2021, International journal of molecular sciences.

[10]  Ho Yun Lee,et al.  Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss , 2021, Journal of audiology & otology.

[11]  K. Ikeda,et al.  Modeling gap junction beta 2 gene-related deafness with human iPSC. , 2021, Human molecular genetics.

[12]  Sarah E. Maurrasse,et al.  Intratympanic Steroid Injection , 2021 .

[13]  Martin L Basch,et al.  Congenital Deafness and Recent Advances Towards Restoring Hearing Loss , 2021, Current protocols.

[14]  A. Büchner,et al.  A MultiCenter Analysis of Factors Associated with Hearing Outcome for 2,735 Adults with Cochlear Implants , 2021, Trends in hearing.

[15]  X. Bai.  Stem Cell-Based Disease Modeling and Cell Therapy , 2020, Cells.

[16]  Bernd Fritzsch,et al.  Combined Atoh1 and Neurod1 Deletion Reveals Autonomous Growth of Auditory Nerve Fibers , 2020, Molecular Neurobiology.

[17]  M. Toyoda,et al.  Application of Mesenchymal Stem Cell Therapy and Inner Ear Regeneration for Hearing Loss: A Review , 2020, International journal of molecular sciences.

[18]  J. Knoblich,et al.  Human organoids: model systems for human biology and medicine , 2020, Nature Reviews Molecular Cell Biology.

[19]  E. Hashino,et al.  Progress in Modeling and Targeting Inner Ear Disorders with Pluripotent Stem Cells , 2020, Stem cell reports.

[20]  M. Ralli,et al.  Dietary Restriction for The Treatment of Meniere’s Disease , 2020, Translational medicine @ UniSa.

[21]  Makoto Hosoya,et al.  A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4 , 2020, Medicine.

[22]  A. Gallego-Martinez,et al.  Burden of Rare Variants in the OTOG Gene in Familial Meniere's Disease. , 2020, Ear and hearing.

[23]  Ae-Ri Ji,et al.  Generation of Otic Lineages from Integration-Free Human-Induced Pluripotent Stem Cells Reprogrammed by mRNAs , 2020, Stem cells international.

[24]  J. Lopez-Escamez,et al.  Current Understanding and Clinical Management of Meniere's Disease: A Systematic Review , 2019, Seminars in Neurology.

[25]  S. Heller,et al.  Novel insights into inner ear development and regeneration for targeted hearing loss therapies , 2019, Hearing Research.

[26]  E. Hashino,et al.  Generation of inner ear organoids from human pluripotent stem cells. , 2020, Methods in cell biology.

[27]  M. E. Gallardo,et al.  The Challenge of Bringing iPSCs to the Patient , 2019, International journal of molecular sciences.

[28]  P. Real,et al.  GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant. , 2019, Stem cell research.

[29]  M. Lako,et al.  Differentiation of Retinal Organoids from Human Pluripotent Stem Cells. , 2019, Current protocols in stem cell biology.

[30]  K. Peng,et al.  Fluctuating Sensorineural Hearing Loss , 2019, Audiology and Neurotology.

[31]  M. Kelley,et al.  Pou4f1 Defines a Subgroup of Type I Spiral Ganglion Neurons and Is Necessary for Normal Inner Hair Cell Presynaptic Ca2+ Signaling , 2019, The Journal of Neuroscience.

[32]  F. Rodríguez-Serrano,et al.  Hearing regeneration and regenerative medicine: present and future approaches , 2019, Archives of medical science : AMS.

[33]  M. Avci-Adali,et al.  Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA , 2019, Stem cells international.

[34]  E. Hashino,et al.  Defective Tmprss3-Associated Hair Cell Degeneration in Inner Ear Organoids , 2019, Stem cell reports.

[35]  C. Sergi,et al.  Growth and cellular patterning during fetal human inner ear development studied by a correlative imaging approach , 2019, BMC Developmental Biology.

[36]  B. Nayagam,et al.  Generation of Vestibular Tissue-Like Organoids From Human Pluripotent Stem Cells Using the Rotary Cell Culture System , 2019, Front. Cell Dev. Biol..

[37]  J. Bohorquez,et al.  Effect of Bone Marrow‐Derived Mesenchymal Stem Cells on Cochlear Function in an Experimental Rat Model , 2019, Anatomical record.

[38]  H. Okano,et al.  Estimating the concentration of therapeutic range using disease-specific iPS cells: Low-dose rapamycin therapy for Pendred syndrome , 2018, Regenerative therapy.

[39]  S. Assou,et al.  Enriched Differentiation of Human Otic Sensory Progenitor Cells Derived From Induced Pluripotent Stem Cells , 2018, Front. Mol. Neurosci..

[40]  K. Qian,et al.  Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells , 2018, Stem Cell Research & Therapy.

[41]  Nerissa K. Kirkwood,et al.  Generating inner ear organoids containing putative cochlear hair cells from human pluripotent stem cells , 2018, Cell Death & Disease.

[42]  B. Neel,et al.  Vitamin C in Stem Cell Reprogramming and Cancer. , 2018, Trends in cell biology.

[43]  Cui Zhang,et al.  Differentiation and transplantation of human induced pluripotent stem cell-derived otic epithelial progenitors in mouse cochlea , 2018, Stem Cell Research & Therapy.

[44]  J. Lopez-Escamez,et al.  Towards personalized medicine in Ménière’s disease , 2018, F1000Research.

[45]  Sun Myoung Kim,et al.  Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success , 2018, Front. Mol. Neurosci..

[46]  E. Nivet,et al.  Modeling human early otic sensory cell development with induced pluripotent stem cells , 2018, PloS one.

[47]  Yu-Ting Wu,et al.  ATOH1/RFX1/RFX3 transcription factors facilitate the differentiation and characterisation of inner ear hair cell-like cells from patient-specific induced pluripotent stem cells harbouring A8344G mutation of mitochondrial DNA , 2018, Cell Death & Disease.

[48]  Kenneth L. Jones,et al.  High-efficiency RNA-based reprogramming of human primary fibroblasts , 2018, Nature Communications.

[49]  J. Brant,et al.  Challenges and opportunities in developing targeted molecular imaging to determine inner ear defects of sensorineural hearing loss. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[50]  J. Lopez-Escamez,et al.  Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross‐sectional study with cluster analysis , 2017, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[51]  Bernd Fritzsch,et al.  NEUROG1 Regulates CDK2 to Promote Proliferation in Otic Progenitors , 2017, Stem cell reports.

[52]  D. Chan,et al.  Diagnosis and Treatment of Congenital Sensorineural Hearing Loss , 2017, Current Otorhinolaryngology Reports.

[53]  Robert A Dobie,et al.  Declining Prevalence of Hearing Loss in US Adults Aged 20 to 69 Years , 2017, JAMA otolaryngology-- head & neck surgery.

[54]  T. Requena,et al.  Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere’s disease , 2017, European Journal of Human Genetics.

[55]  H. Ueda,et al.  Cochlear Cell Modeling Using Disease-Specific iPSCs Unveils a Degenerative Phenotype and Suggests Treatments for Congenital Progressive Hearing Loss. , 2017, Cell reports.

[56]  Zachery D. Morrissey,et al.  Directed Differentiation of Human Embryonic Stem Cells Toward Placode‐Derived Spiral Ganglion‐Like Sensory Neurons , 2016, Stem cells translational medicine.

[57]  Ping Chen,et al.  Induction of differentiation of human embryonic stem cells into functional hair-cell-like cells in the absence of stromal cells. , 2016, The international journal of biochemistry & cell biology.

[58]  T. Noda,et al.  In Vitro Models of GJB2-Related Hearing Loss Recapitulate Ca2+ Transients via a Gap Junction Characteristic of Developing Cochlea , 2016, Stem cell reports.

[59]  A. Vallesi,et al.  Aging, Cognitive Decline and Hearing Loss: Effects of Auditory Rehabilitation and Training with Hearing Aids and Cochlear Implants on Cognitive Function and Depression among Older Adults , 2016, Audiology and Neurotology.

[60]  Su-Chun Zhang,et al.  Chemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's Disease. , 2016, Cell stem cell.

[61]  Ping Chen,et al.  Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell‐Like Cells , 2016, Stem cells translational medicine.

[62]  Yue Deng,et al.  Olfactory epithelium neural stem cell implantation restores noise-induced hearing loss in rats , 2016, Neuroscience Letters.

[63]  Chao Zhang,et al.  Effects of genetic correction on the differentiation of hair cell-like cells from iPSCs with MYO15A mutation , 2016, Cell Death and Differentiation.

[64]  N. Benvenisty,et al.  Pluripotent stem cells in disease modelling and drug discovery , 2016, Nature Reviews Molecular Cell Biology.

[65]  J. Rinn,et al.  A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs , 2015, Nature Biotechnology.

[66]  S. Yamada,et al.  Morphogenesis of the Inner Ear at Different Stages of Normal Human Development , 2015, Anatomical record.

[67]  P. Real,et al.  Generation of human iPSC line GRX-MCiPS4F-A2 from adult peripheral blood mononuclear cells (PBMCs) with Spanish genetic background. , 2015, Stem cell research.

[68]  M. Strupp,et al.  Diagnostic criteria for Menière's disease. , 2015, Journal of vestibular research : equilibrium & orientation.

[69]  Tatsunori Sakamoto,et al.  Limited hair cell induction from human induced pluripotent stem cells using a simple stepwise method , 2015, Neuroscience Letters.

[70]  Anna Lysakowski,et al.  Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere's disease. , 2015, Human molecular genetics.

[71]  Xin Li,et al.  A comparison of non-integrating reprogramming methods , 2014, Nature Biotechnology.

[72]  V. Salomaa,et al.  Advanced Feeder‐Free Generation of Induced Pluripotent Stem Cells Directly From Blood Cells , 2014, Stem cells translational medicine.

[73]  D. Crombie,et al.  Directing Human Induced Pluripotent Stem Cells into a Neurosensory Lineage for Auditory Neuron Replacement , 2014, BioResearch open access.

[74]  S. Heller,et al.  Inner ear hair cell-like cells from human embryonic stem cells. , 2014, Stem cells and development.

[75]  K. Needham,et al.  Electrophysiological properties of neurosensory progenitors derived from human embryonic stem cells. , 2014, Stem cell research.

[76]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[77]  Dharmeshkumar Patel,et al.  Generation of inner ear sensory epithelia from pluripotent stem cells in 3D culture , 2013, Nature.

[78]  L. Kottam,et al.  Inner ear progenitor cells can be generated in vitro from human bone marrow mesenchymal stem cells. , 2012, Regenerative medicine.

[79]  J. García-Sancho,et al.  Generation of inner ear sensory cells from bone marrow-derived human mesenchymal stem cells. , 2012, Regenerative medicine.

[80]  Stuart L. Johnson,et al.  Restoration of auditory evoked responses by human ES cell-derived otic progenitors , 2012, Nature.

[81]  Yoshiki Sasai,et al.  Self-formation of optic cups and storable stratified neural retina from human ESCs. , 2012, Cell stem cell.

[82]  G. Ming,et al.  Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells , 2012, Molecular Brain.

[83]  Kristopher L. Nazor,et al.  Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.

[84]  Naoki Nishishita,et al.  Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors , 2011, Proceedings of the National Academy of Sciences.

[85]  Mitsugu Sekimoto,et al.  Reprogramming of mouse and human cells to pluripotency using mature microRNAs. , 2011, Cell stem cell.

[86]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[87]  Robert L. Judson,et al.  Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells , 2011, Nature Biotechnology.

[88]  Junying Yu,et al.  Efficient Feeder-Free Episomal Reprogramming with Small Molecules , 2011, PloS one.

[89]  Elizabeth E. Hoskins,et al.  Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro , 2010, Nature.

[90]  Sheng Ding,et al.  Reprogramming of human primary somatic cells by OCT4 and chemical compounds. , 2010, Cell stem cell.

[91]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[92]  Y. Kan,et al.  Generation of induced pluripotent stem cells using site-specific integration with phage integrase , 2010, Proceedings of the National Academy of Sciences.

[93]  Jun Wang,et al.  Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG. , 2010, Differentiation; research in biological diversity.

[94]  Z. Bosnjak,et al.  Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors , 2010, BMC Developmental Biology.

[95]  D. Givol,et al.  Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. , 2010, Biochemical and biophysical research communications.

[96]  Deepak M. Gupta,et al.  A nonviral minicircle vector for deriving human iPS cells , 2010, Nature Methods.

[97]  James A Thomson,et al.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency , 2010, Proceedings of the National Academy of Sciences.

[98]  K. Francis,et al.  Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning , 2010, Cell Death and Disease.

[99]  H. Rehm,et al.  Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. , 2010, Archives of otolaryngology--head & neck surgery.

[100]  H. Redl,et al.  Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. , 2010, Cell stem cell.

[101]  H. Schöler,et al.  Generation of Human‐Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2 , 2009, Stem cells.

[102]  Wenbo Zhou,et al.  Adenoviral Gene Delivery Can Reprogram Human Fibroblasts to Induced Pluripotent Stem Cells , 2009, Stem cells.

[103]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[104]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[105]  G. Daley,et al.  Generation of induced pluripotent stem cells from human blood. , 2009, Blood.

[106]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[107]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[108]  K. Woltjen,et al.  Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.

[109]  Xiaolei Yin,et al.  Two supporting factors greatly improve the efficiency of human iPSC generation. , 2008, Cell stem cell.

[110]  A. Consiglio,et al.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.

[111]  Donald C. Chang,et al.  Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. , 2008, RNA.

[112]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[113]  P. Mali,et al.  Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts , 2008, Stem cells.

[114]  Jiuhong Kang,et al.  Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors , 2008, Cell Research.

[115]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[116]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[117]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[118]  T. Graf.  Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[119]  Adrian James,et al.  Menière's disease. , 2007, BMJ clinical evidence.

[120]  E. Oestreicher,et al.  Neurotransmission of the cochlear inner hair cell synapse--implications for inner ear therapy. , 2002, Advances in oto-rhino-laryngology.

[121]  K. Mizuseki,et al.  Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity , 2000, Neuron.